BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc.verified

BBIO

Price:

$27.86

Market Cap:

$5.21B

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor, which is Phase 2 clinical trial to treat achondroplasia in pediatric patients; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 2 clinical trial for ...[Read more]

Industry

Biotechnology

IPO Date

2019-06-27

Stock Exchange

NASDAQ

Ticker

BBIO

The PE Ratio as of June 2024 (TTM) for BridgeBio Pharma, Inc. (BBIO) is -8.63

According to BridgeBio Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.63. This represents a change of -41.45% compared to the average of -14.74 of the last 4 quarters.

BridgeBio Pharma, Inc. (BBIO) Historical PE Ratio (quarterly & annually)

How has BBIO PE Ratio performed in the past?

The mean historical PE Ratio of BridgeBio Pharma, Inc. over the last ten years is -21.49. The current -8.63 PE Ratio has changed 3.92% with respect to the historical average. Over the past ten years (40 quarters), BBIO's PE Ratio was at its highest in in the June 2022 quarter at 5.61. The PE Ratio was at its lowest in in the March 2024 quarter at -38.03.

Quarterly (TTM)
Annual

Average

-21.49

Median

-14.14

Minimum

-83.22

Maximum

-2.27

BridgeBio Pharma, Inc. (BBIO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BridgeBio Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 349.13%

Maximum Annual PE Ratio = -2.27

Minimum Annual Increase = -78.28%

Minimum Annual PE Ratio = -83.22

Quarterly (TTM)
Annual
YearPE RatioChange
2023-10.22349.13%
2022-2.27-39.60%
2021-3.77-78.28%
2020-17.3422.58%
2019-14.14-27.30%
2018-19.45-76.62%

BridgeBio Pharma, Inc. (BBIO) Average PE Ratio

How has BBIO PE Ratio performed in the past?

The current PE Ratio of BridgeBio Pharma, Inc. (BBIO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.42

5-year avg

-9.55

10-year avg

-21.49

BridgeBio Pharma, Inc. (BBIO) PE Ratio vs. Peers

How is BBIO’s PE Ratio compared to its peers?

BridgeBio Pharma, Inc.’s PE Ratio is greater than IVERIC bio, Inc. (-33.43), greater than Blueprint Medicines Corporation (-22.55), less than Amylyx Pharmaceuticals, Inc. (-1.57), greater than Karuna Therapeutics, Inc. (-29.52), less than Day One Biopharmaceuticals, Inc. (-5.23), less than Mirati Therapeutics, Inc. (-5.32), less than Terns Pharmaceuticals, Inc. (-6.70), greater than Apellis Pharmaceuticals, Inc. (-12.38), greater than Cerevel Therapeutics Holdings, Inc. (-16.38), less than PTC Therapeutics, Inc. (-4.73), less than Krystal Biotech, Inc. (88.00), greater than Intercept Pharmaceuticals, Inc. (-13.55), greater than Madrigal Pharmaceuticals, Inc. (-12.50), less than Acumen Pharmaceuticals, Inc. (-2.82), less than Inozyme Pharma, Inc. (-3.80), less than X4 Pharmaceuticals, Inc. (-1.58),

Build a custom stock screener for BridgeBio Pharma, Inc. (BBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BridgeBio Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BridgeBio Pharma, Inc. (BBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BridgeBio Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is BridgeBio Pharma, Inc.'s PE Ratio?

How is the PE Ratio calculated for BridgeBio Pharma, Inc. (BBIO)?

What is the highest PE Ratio for BridgeBio Pharma, Inc. (BBIO)?

What is the 3-year average PE Ratio for BridgeBio Pharma, Inc. (BBIO)?

What is the 5-year average PE Ratio for BridgeBio Pharma, Inc. (BBIO)?

How does the current PE Ratio for BridgeBio Pharma, Inc. (BBIO) compare to its historical average?